HEALTHTECH COMPANY
TRANSFORMING STEM CELL THERAPY
TRANSFORMING STEM CELL THERAPY
without barriers to regenerative medicine
About Us
We are an early-stage healthtech company developing AI-powered cellular therapies for bone regeneration, born from the scientific and technological research of our founders
ADVANCED THERAPY MEDICAL PRODUCT | ALLOGENIC MESENCHYMAL STEM CELLS PLUS HYALURONIC ACID | EXTRACTION FROM UMBILICAL CORD | EX VIVO & SCALABLE PRODUCTION
Our Mission
To advance regenerative cell therapies for bone injuries, improving healing and quality of life without barriers.
R&D scalable therapies based on mesenchymal stem cells plus hyaluronic acid
Innovative Solutions for treating degenerative diseases and injuries through regenerative medicine
Strategic Partnership with hospitals and research centers to drive the expansion of health technologies
Diversified Revenue Model combining the sale of cutting-edge cellular therapies with ip licensing opportunities in global markets
Value Proposition
INTELLECTUAL PROPERTY
Argentina & PCT
Protocol Production
Ready to use solution without scaffold
Long Term Efficacy
Designed for lifelong effectiveness
Regulatory & Safety Prfile
Offering safety and efficacy
HYALURONIC ACID INNOVATION
Leveraging the Potential of Hyaluronic Acid
To advance regenerative cell
therapies for bone injuries
IMPROVING HEALING AND QUALITY OF LIFE WITHOUT BARRIERS
Timeline and Milestones, past and future

- Finalization of Clinical Study Design
- First Patient Enrollment for Phase 1 Clinical Trial
- Complete Phase 1 Clinical Trial
- Development of Stem Cell Technology Platform

- Regulatory Approval and Market Entry Strategy
- Evaluation Request to ANMAT/INCUCAI for Clinical Application

- Signature of R&D agreement with CONICET - UNNOBA
- Signature of R&D agreement with Hosp. Garrahan
- Product development under GMP in Hosp. Garrahan

- The Research Board of Hospital Garrahan approved the collaboration with the Cord Blood Bank
- Term Sheet for the License Agreement signed with CONICET and UNNOBA

- Project Beginning
- Approval by the SF500 Investment Committee
- Registration Mesenchyal-T Inc
2021
Startup Creation Process
- Project Beginning
- Positive patentability evaluation by CONICET
02/2023
Startup Creation Process
- SF500 BUILD Selection and participation
06/2023
Startup Creation Process
- Patent aplication INPI
- SF500 Investment commitee approva
10/2023
Startup Creation Process
- Participation Regulatory. Assistance Prgogram AR R&D ANMAT
- S.A registration Mesenchyal-T S.A
12/2023
Fundraising Agreements with collaborators
- Aplication to EMPRETECNO 2023 (FONARSEC)
- «Acelerar España 2023»
06/2024
Fundraising Agreements with collaborators
- Patent Aplication PCT
- Reseach board Hosp Garrahan aprobe the colaboration with cord bank
07/2024
Fundraising Agreements with collaborators
- Signature of 75 license agreement CONICET – UNNOBA
- Trademark registration INPI
10/2024
Fundrasing MVP Development
- Signature of R&D agreement with CONICET – UNNOBA
- Signature of R&D agreement with Hosp. Garraham
2024/25
Fundrasing MVP Development
- Product development under GMP in Hosp. Garrhan
- Product development under GMP in Hosp. Garrhan
Next 2025
Regulatory approvals Internationalazation
- Signature of 75 license agreement CONICET – UNNOBA
- Trademark registration INPI
Next 2025
Regulatory approvals Internationalazation
- Signature of R&D agreement with CONICET – UNNOBA
- Signature of R&D agreement with Hosp. Garraham
Next 2025
Regulatory approvals Internationalazation
- Product development under GMP in Hosp. Garrhan
- Product development under GMP in Hosp. Garrhan

Our Innovative
Solution
Is An Advanced Therapy Medicinal Product
Combines Allogenic Mesenchymal Stem Cells With Hyaluronic Acid
We Offer

To regenerate the bone naturally

To reduce time to restore bone fuction and mobility

To reduce treatment time with a single intervention

To reduce complications

AI platform to predict treatment outcomes
OUR TEAM
CONICET Researchers | PhDs | BSs in Genetics | Scientific Technological Entrepreneurs
FOUNDERS
RESEARCH & DEVELOPMENT
ADVISORS
JOIN OUR MISSION

Our Strategic Partnerships
Our team of investor partners, collaborators and sponsors.
Investment fund for high-impact scientific and technological startups
Argentina's leading pediatric hospital, providing specialized medical care, research, and training in child health.
SPECIALIZED LABORATORY CO-WORKING
Business incubation services for technology-based companies
Governmental organization dedicated to the promotion of science and technology in Argentina